Results 161 to 170 of about 3,692,049 (193)

A new c.681dup RUNX1 variant in familial leukemia. [PDF]

Fam Cancer
Crocioni M, Nardelli C, Lema Fernandez AG, Bardelli V, Pierini V, Matteucci C, Beggiato E, Olivi M, Vigliani V, Pelle A, Lanzarone G, Mecucci C.   +11 more
europepmc   +1 more source

Molecular Pathogenesis and Targeted Therapies for Myeloproliferative Hypereosinophilic Neoplasms. [PDF]

Curr Hematol Malig Rep
Hanna C, Rizkallah J, Charbel N, Sakkal S, Haddad FG.   +4 more
europepmc   +1 more source

A microRNA expression signature in infant t(4;11) KMT2A::AFF1+ BCP-ALL uncovers novel therapeutic targets. [PDF]

Hemasphere
Malouf C, Duguid A, Vrenken KS, Leah T, Medhi R, Camiolo G, Nitsche L, Jakobczyk H, Kotecha RS, Anderson RA, Barrett NA, Smith OP, Stam RW, Ottersbach K.   +13 more
europepmc   +1 more source

CD19-negative relapse after CAR-T cell therapy: mechanisms of antigen escape and lineage switch. [PDF]

Front Immunol
Huang J, Huang X, Yu D.
europepmc   +1 more source

T-cell lymphoma of the breast and ovary presenting as a second malignant neoplasm in a pediatric leukemia survivor: A case report and literature review. [PDF]

Rare Tumors
Alvarez-Palacios O, Ojeda-Campos L, Rodríguez A, Díaz-Juarez GE, Figueroa-Torres JM, Juárez-Velázquez R, Juárez-Figueroa U, Gallardo-Navarro JJ, Segundo-Galvez LF, Ocampo-Bárcenas A.   +9 more
europepmc   +1 more source

Smoldering Waldenström macroglobulinemia coexisting with myelodysplastic syndrome: a rare case report and literature review. [PDF]

Front Oncol
Wang H, Tan S, Li Y, Sun W.
europepmc   +1 more source

T cell-engaging bispecific antibodies for myeloid malignancies: Targets, formats, and clinical challenges. [PDF]

Cell Rep Med
Paczesny S, Barwe SP, Gopalakrishnapillai A, Cheung NV.   +3 more
europepmc   +1 more source

Lymphoid malignancy and clonality in the POT1-mediated long telomere syndrome.

Blood
Davidson-Swinton HR, Iyer S, Kolchinski A, Salem JA, DeBoy EA, Kilada AG, Hwang JS, Jain T, Keel SB, Gocke CD, Zou YS, Schratz KE, Armanios M.   +12 more
europepmc   +1 more source

The <i>NFIA::CBFA2T3</i> identifies a molecularly defined subgroup of acute erythroid leukemia/erythroid sarcoma. [PDF]

Front Oncol
Brunetti M, Andersen K, Tjønnfjord GE, Zeller B, Spetalen S, Munthe-Kaas MC, Osnes LTN, Os TT, Micci F.   +8 more
europepmc   +1 more source

SLC39A6 as a pan-cancer promising biomarker and actionable therapeutic target for CH5132799 sensitivity. [PDF]

BMC Cancer
Hongmin L, Yufei W, Yuwei W, Dongqi Y, Mengjie L, Yudong S, Peng C, Jinghua Z.   +7 more
europepmc   +1 more source